Back

Temporal trends and outcomes of superelderly patients undergoing coronary intervention with and without acute myocardial infarction: Insights from the Japanese nationwide registry

31 August 2026 (08:33 - 08:51)
Organised by: Logo
Congress Presentation Part of: Percutaneous coronary intervention and adjunctive therapeutic strategies Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Yuichi Saito

Chiba University Hospital, Chiba (Japan)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on percutaneous coronary intervention and adjunctive therapeutic strategies
Doctor G. Stone (New York City, US)
Presentation thumbnail
Drug-coated balloons angioplasty versus drug-eluting stents for coronary artery bypass graft
Doctor T. Aikawa (Tokyo, JP)
Abstract
Presentation thumbnail
One- versus three-month dual antiplatelet therapy in high-bleeding-risk patients undergoing PCI: a bayesian and trial sequential meta-analysis
Doctor K. Mahajan (Mandi, IN)
Abstract
Presentation thumbnail
Dual impairment of thrombotic and fibrinolytic pathways assessed by the global thrombosis test predicts adverse clinical outcomes after percutaneous coronary intervention
Professor J. Suh (Seongnam, KR)
Abstract

Access the full session

Session thumbnail
Percutaneous coronary intervention and adjunctive therapeutic strategies

The Event

Event poster

ESC Congress 2026

31 August 2026 08:33 CET
You may be interested in
thumbnail
Congress Presentation
Percutaneous coronary intervention in the age of frailty
2 September 2019
thumbnail
Congress Presentation
Temporal trends in long coronary chronic total occlusion interventions: the Japanese CTO-PCI expert registry
1 September 2025
thumbnail
Congress Presentation
Temporal trends and outcomes of cardiac rehabilitation after acute coronary syndrome in an asian population
4 April 2025
thumbnail
Congress Presentation
Incidence and risk factors of perioperative myocardial injury after non-cardiac surgery in JAPAN: a prospective observational multicenter cohort study
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources